Strategic Financial Concepts LLC Invests $3.83 Million in VanEck Biotech ETF (NASDAQ:BBH)

Strategic Financial Concepts LLC bought a new position in shares of VanEck Biotech ETF (NASDAQ:BBH) during the fourth quarter, Holdings Channel reports. The fund bought 24,385 shares of the company’s stock, valued at approximately $3,828,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Flagship Harbor Advisors LLC raised its holdings in shares of VanEck Biotech ETF by 12.1% during the fourth quarter. Flagship Harbor Advisors LLC now owns 1,984 shares of the company’s stock valued at $311,000 after acquiring an additional 214 shares during the period. Janney Montgomery Scott LLC acquired a new stake in VanEck Biotech ETF during the 4th quarter valued at $481,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of VanEck Biotech ETF in the third quarter valued at $166,000. Jane Street Group LLC boosted its position in shares of VanEck Biotech ETF by 401.7% in the third quarter. Jane Street Group LLC now owns 8,348 shares of the company’s stock worth $1,481,000 after buying an additional 6,684 shares during the period. Finally, Kovitz Investment Group Partners LLC grew its holdings in shares of VanEck Biotech ETF by 4.6% during the third quarter. Kovitz Investment Group Partners LLC now owns 3,186 shares of the company’s stock valued at $565,000 after buying an additional 141 shares in the last quarter. 32.05% of the stock is owned by institutional investors and hedge funds.

VanEck Biotech ETF Price Performance

Shares of VanEck Biotech ETF stock opened at $160.56 on Monday. VanEck Biotech ETF has a 1 year low of $151.35 and a 1 year high of $183.64. The stock has a 50-day moving average price of $161.38 and a 200 day moving average price of $169.80.

VanEck Biotech ETF Dividend Announcement

The business also recently declared a dividend, which was paid on Tuesday, December 24th. Investors of record on Monday, December 23rd were issued a dividend of $1.2517 per share. The ex-dividend date of this dividend was Monday, December 23rd.

VanEck Biotech ETF Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.